Ther reversal of experimental vasospasm by dibutyryl-3',5'-adenosine monophosphate.
D000818:Animals; D001488:Basilar Artery / Q000187:drug effects; D001794:Blood Pressure; D002087:Butyrates / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D002415:Cats; D003250:Constriction; D000242:Cyclic AMP / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D004106:Dilatation; D005260:Female; D006339:Heart Rate; D002546:Ischemic Attack, Transient / Q000188:drug therapy* / Q000209:etiology; D008297:Male; D013345:Subarachnoid Hemorrhage / Q000150:complications; D013806:Theophylline / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use*
D002087:Butyrates; D014665:Vasodilator Agents; D013806:Theophylline; D000242:Cyclic AMP